Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for REPLIGEN CORP COMMON STOCK (RGEN).
- Disclosed ownership: 8.2%.
- Date of event: 31 Dec 2025.
PRICE T ROWE ASSOCIATES INC /MD/ - 31 Dec 2025 SCHEDULE 13G/A Report for REPLIGEN CORP COMMON STOCK (RGEN)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Security
- REPLIGEN CORP COMMON STOCK
- Symbol
- RGEN
- Shares outstanding
- 56,095,854 shares
- Disclosed Ownership
- 4,599,860 shares
- Ownership
- 8.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 10:26:21 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 08 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 8.2% ownership in REPLIGEN CORP COMMON STOCK (RGEN) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 08 Sep 2025.
- Current filing was accepted on 17 Feb 2026, 10:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 8.2% | 4,599,860 | 4,301,925 | 0 | Ellen York | Vice President |